NCT00392925 - A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects | Biotech Hunter

Enrollment

177

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

OverweightObesity

Interventions

DRUG

pramlintide acetate 360 mcg

subcutaneous injection, twice a day, 360mcg

DRUG

metreleptin

subcutaneous injection, twice a day, 5mg

DRUG

placebo-pramlintide 600 uL

twice a day

DRUG

placebo-metreleptin 1 mL

twice a day

DRUG

Pramlintide acetate 180 mcg

subcutaneous injection twice a day, 180 mcg

Trial Locations (12)

Research Site, DeLand

Research Site, Chicago

Research Site, Indianapolis

Research Site, Overland Park

Research Site, Baton Rouge

Research Site, Detroit

Research Site, Edina

Research Site, Butte

Research Site, Cincinnati

Research Site, Portland

Research Site, Salt Lake City

Research Site, Olympia